BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 38596619)

  • 1. A 24-year-Old woman with recurrent pneumothoraces.
    Greenberg DJ; Sah A; Chopra A; Madisi N
    Respir Med Case Rep; 2024; 49():102015. PubMed ID: 38596619
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Pulmonary lymphangioleiomyomatosis: report of one case].
    Silva O R; Puelma C F; Retamal P V; Rojas Sm P; Cruzat C C; Reyes G C
    Rev Med Chil; 2009 Nov; 137(11):1474-7. PubMed ID: 20098807
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pulmonary Lymphangioleiomyomatosis: A Case Report and Literature Review.
    Sathirareuangchai S; Shimizu D; Vierkoetter KR
    Hawaii J Health Soc Welf; 2020 Jul; 79(7):224-229. PubMed ID: 32666056
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduced risk of recurrent pneumothorax for sirolimus therapy after surgical pleural covering of entire lung in lymphangioleiomyomatosis.
    Sakurai T; Arai T; Hirose M; Kojima K; Sakamoto T; Matsuda Y; Sugimoto C; Yoon HE; Inoue Y
    Orphanet J Rare Dis; 2021 Nov; 16(1):466. PubMed ID: 34732225
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lymphangioleiomyomatosis (LAM) presenting as recurrent pneumothorax in an infant with tuberous sclerosis: treated successfully with sirolimus.
    Takia L; Jat KR; Mandal A; Kabra SK
    BMJ Case Rep; 2018 Nov; 2018():. PubMed ID: 30413450
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum vascular endothelial growth factor-D prospectively distinguishes lymphangioleiomyomatosis from other diseases.
    Young LR; Vandyke R; Gulleman PM; Inoue Y; Brown KK; Schmidt LS; Linehan WM; Hajjar F; Kinder BW; Trapnell BC; Bissler JJ; Franz DN; McCormack FX
    Chest; 2010 Sep; 138(3):674-81. PubMed ID: 20382711
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Lung lymphangioleiomyomatosis (LAM)].
    Cukić V; Lovre V; Beslić S; Bilalović N; Guska S
    Med Arh; 2008; 62(3):180-2. PubMed ID: 18822952
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical features, epidemiology, and therapy of lymphangioleiomyomatosis.
    Taveira-DaSilva AM; Moss J
    Clin Epidemiol; 2015; 7():249-57. PubMed ID: 25897262
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Lymphangioleiomyomatosis - new concepts on pathogenesis, diagnosis and treatment].
    Sobiecka M
    Wiad Lek; 2016; 69(2 Pt 1):123-9. PubMed ID: 27421126
    [TBL] [Abstract][Full Text] [Related]  

  • 10. EPIDEMIOLOGY, PATHOGENESIS and DIAGNOSIS of LYMPHANGIOLEIOMYOMATOSIS.
    Taveira-DaSilva AM; Moss J
    Expert Opin Orphan Drugs; 2016; 4(4):369-378. PubMed ID: 27833825
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lymphangioleiomyomatosis: differential diagnosis and optimal management.
    Xu KF; Lo BH
    Ther Clin Risk Manag; 2014; 10():691-700. PubMed ID: 25187723
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A rare pulmonary lymphangioleiomyomatosis disease in a male with tuberous sclerosis complex.
    Kabi A; Panda S; Sama S; Kumar S; Kaeley N; Sogal P S
    Respir Med Case Rep; 2020; 31():101150. PubMed ID: 32695569
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic and Treatment Monitoring Potential of Serum Vascular Endothelial Growth Factor-D in Lymphangioleiomyomatosis.
    Mou Y; Ye L; Wang J; Yee MS; Song YL; Zhu L; Jin ML
    Lymphology; 2016 Sep; 49(3):140-9. PubMed ID: 29906075
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and molecular insights into lymphangioleiomyomatosis.
    Steagall WK; Taveira-DaSilva AM; Moss J
    Sarcoidosis Vasc Diffuse Lung Dis; 2005 Dec; 22 Suppl 1():S49-66. PubMed ID: 16457017
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lymphangioleiomyomatosis in patients with tuberous sclerosis: a national centre audit.
    Johnson J; Somerfield W; Johnson SR
    Orphanet J Rare Dis; 2024 Mar; 19(1):137. PubMed ID: 38532450
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeted approaches toward understanding and treating pulmonary lymphangioleiomyomatosis (LAM).
    Hammes SR; Krymskaya VP
    Horm Cancer; 2013 Apr; 4(2):70-7. PubMed ID: 23184699
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention of alveolar destruction and airspace enlargement in a mouse model of pulmonary lymphangioleiomyomatosis (LAM).
    Goncharova EA; Goncharov DA; Fehrenbach M; Khavin I; Ducka B; Hino O; Colby TV; Merrilees MJ; Haczku A; Albelda SM; Krymskaya VP
    Sci Transl Med; 2012 Oct; 4(154):154ra134. PubMed ID: 23035046
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The natural history of lymphangioleiomyomatosis: markers of severity, rate of progression and prognosis.
    Taveira-DaSilva AM; Pacheco-Rodriguez G; Moss J
    Lymphat Res Biol; 2010 Mar; 8(1):9-19. PubMed ID: 20235883
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and histopathological alterations of lymphangioleiomyomatosis in 14 Chinese patients.
    Lu SH; Hou YY; Tan YS; Xu JF; Zeng HY; Sujie AK; Wang XD; Bai CX
    Chin Med J (Engl); 2009 Aug; 122(16):1895-900. PubMed ID: 19781367
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Secondary spontaneous pneumothorax in tuberous sclerosis].
    Kyriss T; Eulenbruch H; Friedel G; Toomes H; Bosse A
    Chirurg; 2001 Dec; 72(12):1504-7. PubMed ID: 11824039
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.